Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Fondaparinux in Critically Ill Patients With Renal Failure

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Wayne State University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Steven Dov Tennenberg, MD, Wayne State University
ClinicalTrials.gov Identifier:
NCT01467583
First received: November 3, 2011
Last updated: July 16, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2013
  Estimated Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)